PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy

Clinical trial NCT05246670 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05246670
Sponsor: Academic and Community Cancer Research United
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-Induced Peripheral Neuropathy Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

Start date: 2022-05-16
Primary completion: 2024-02-12
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.